rs4889606
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_052874.5(STX1B):c.280+1066T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.354 in 152,030 control chromosomes in the GnomAD database, including 10,925 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.35 ( 10925 hom., cov: 32)
Consequence
STX1B
NM_052874.5 intron
NM_052874.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.240
Publications
45 publications found
Genes affected
STX1B (HGNC:18539): (syntaxin 1B) The protein encoded by this gene belongs to a family of proteins thought to play a role in the exocytosis of synaptic vesicles. Vesicle exocytosis releases vesicular contents and is important to various cellular functions. For instance, the secretion of transmitters from neurons plays an important role in synaptic transmission. After exocytosis, the membrane and proteins from the vesicle are retrieved from the plasma membrane through the process of endocytosis. Mutations in this gene have been identified as one cause of fever-associated epilepsy syndromes. A possible link between this gene and Parkinson's disease has also been suggested. [provided by RefSeq, Jan 2015]
STX1B Gene-Disease associations (from GenCC):
- generalized epilepsy with febrile seizures plusInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- generalized epilepsy with febrile seizures plus, type 9Inheritance: AD Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.869 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.354 AC: 53765AN: 151912Hom.: 10917 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
53765
AN:
151912
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.354 AC: 53797AN: 152030Hom.: 10925 Cov.: 32 AF XY: 0.356 AC XY: 26478AN XY: 74320 show subpopulations
GnomAD4 genome
AF:
AC:
53797
AN:
152030
Hom.:
Cov.:
32
AF XY:
AC XY:
26478
AN XY:
74320
show subpopulations
African (AFR)
AF:
AC:
9015
AN:
41476
American (AMR)
AF:
AC:
6185
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
AC:
1742
AN:
3468
East Asian (EAS)
AF:
AC:
4608
AN:
5176
South Asian (SAS)
AF:
AC:
917
AN:
4816
European-Finnish (FIN)
AF:
AC:
4152
AN:
10560
Middle Eastern (MID)
AF:
AC:
159
AN:
294
European-Non Finnish (NFE)
AF:
AC:
25764
AN:
67942
Other (OTH)
AF:
AC:
851
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1682
3363
5045
6726
8408
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
504
1008
1512
2016
2520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1629
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.